RACHEL COLLINS: Open Payments
NPI 1154669265 · CONWAY, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,087 in 46 payments from 19 companies in 2025. Trend: 2023 $533 · 2024 $769 · 2025 $1,087
Food & beverage: $1,087
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $160 |
| Novo Nordisk Inc | 4 | $95 |
| Xeris Pharmaceuticals, Inc. | 4 | $89 |
| SANOFI-AVENTIS U.S. LLC | 2 | $87 |
| BETA BIONICS, INC. | 3 | $79 |
| Amgen Inc. | 4 | $74 |
| Corcept Therapeutics | 3 | $59 |
| Ascensia Diabetes Care Us Inc. | 2 | $54 |
| Radius Health, Inc. | 2 | $53 |
| Medtronic, Inc. | 3 | $49 |
Products named: MOUNJARO, TZIELD, iLet Bionic Pancreas, GVOKE HYPOPEN, Ozempic, Korlym, JARDIANCE, Tymlos.
Industry payments across SC — which companies pay providers there.
